TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ranking on the HEC Paris-Dow Jones 2025 Global ...
Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC). Targeting germline or somatic DNA repair defects (beyond BRCA) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results